DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Eli Lilly - 1 LLY.N - 1 Jaypirca - 1 Christy Santhosh - 1 Arun Koyyur - 1
Top related locs:
Bengaluru
Top related orgs:
U.S . Food - 1 Drug Administration - 1 FDA - 1 National Institutes of Health - 1 CLL - 1 Thomson - 1

Search resuls for: "CLL"


3 mentions found


☆ US FDA gives second approval to Eli Lilly's drug for type of blood cancer
  + stars: | 2023-12-01 | by ( ) www.reuters.com   time to read: +1 min
Dec 1 (Reuters) - Eli Lilly (LLY.N) said on Friday the U.S. Food and Drug Administration (FDA) gave a second approval for its drug Jaypirca, which is used to treat a form of blood cancer. The company said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of cancer in which the bone marrow makes too many of certain white blood cells. Jaypirca was first given accelerated approval by the FDA on Jan. 27 for the treatment of mantle cell lymphoma (MCL), a rare type of blood cancer that starts in white blood cells and spreads to other parts of the body. MCL is a more aggressive form of cancer compared to CLL, according to the National Institutes of Health. The drug aims to treat adults with CLL after at least two lines of therapy.
Persons: Eli Lilly, LLY.N, Jaypirca, Christy Santhosh, Arun Koyyur Organizations: U.S . Food, Drug Administration, FDA, National Institutes of Health, CLL, Thomson Locations: Bengaluru
☆ Homebuyers will be able to get bigger mortgages in 2023 but it could be a bad idea for Americans to stretch their budgets too far
  + stars: | 2023-01-05 | by ( Alcynna Lloyd | ) www.businessinsider.com   time to read: +6 min
The Federal Housing Finance Agency raised its conforming loan limit values for mortgages in 2023. In most of the US, the agency raised the conforming loan value from $647,200 to $726,200. However, updates from The Federal Housing Finance Agency, which has increased its conforming loan limit values for Fannie Mae and Freddie Mac mortgages in 2023, will likely change the equation for many homebuyers. However, in high-cost areas of the country, such as New York City or San Francisco, the loan limit ceiling has been changed to $1,089,300. Higher loan limits are a double edged sword for first-time buyersCohn is not alone in her thinking.
☆ Multiple revenue misses in one of our winners convinced us to take profits and get out
  + stars: | 2022-10-28 | by ( Jeff Marks | ) www.cnbc.com   time to read: +6 min
Imbruvica: $1.14 billion versus $1.15 billion expected. Venclexta: $515 million versus $550 million expected. Lumigan/Ganfort: $121 million versus $130 million expected. Alphagan: $73 million versus $92 million expected. Restasis: $142 million versus $47 million expected.
0 next >>
Total: 3